VF
NXTC icon

Virtu Financial’s NextCure NXTC Stock Holding History

Virtu Financial’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,913
Closed -$18K – 1836
2024
Q4 		$18K Buy
+1,913
New +$28.1K ﹤0.01% 1316
2024
Q1 		– Sell
-2,213
Closed -$30K – 1886
2023
Q4 		$30K Buy
+2,213
New +$32.1K ﹤0.01% 1255
2023
Q1 		– Sell
-1,632
Closed -$28K – 1924
2022
Q4 		$28K Buy
+1,632
New +$37.5K ﹤0.01% 1197

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial's NXTC Position: Q1 2025 in Review

Virtu Financial sold out of NextCure (NXTC) in Q1 2025, closing a stake of 1,913 shares — an estimated $18K sold.

Virtu Financial first reported a position in NXTC in Q4 2022 and held it in 3 quarters. The position peaked at $30K in Q4 2023. 38 funds tracked by Wall St. Rank hold NXTC as of Q1 2025.

  • Virtu Financial reported no remaining NextCure position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 1,913 NextCure shares in Q1 2025, an estimated $18K.
  • Virtu Financial first reported a position in NextCure in Q4 2022 and held it in 3 quarters.
  • Virtu Financial's NextCure position peaked at $30K in Q4 2023.
  • 38 funds tracked by Wall St. Rank held NextCure as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.